Identification and characterization of DEDDL, a human-specific isoform of DEDD

Gene Expression

Volumn 13, Issue 3, 2006, Pages 141-153

  Huang, Xin ^a   Zhang, Minghui ^a   Tang, Hua ^a   Ruo, Chunfang ^a   Cao, Xuetao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alternative splice variant; Apoptosis; Death effector domain (DED); Dendritic cells

Indexed keywords

BETA ACTIN; CASPASE; DNA DIRECTED RNA POLYMERASE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; GENE PRODUCT; ISOPROTEIN; MESSENGER RNA; PROTEIN DEDD; PROTEIN DEDDL; UNCLASSIFIED DRUG; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEDD PROTEIN, HUMAN; DNA BINDING PROTEIN; FADD PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNIP2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL MATURATION; CELL SPECIFICITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DENDRITIC CELL; ENZYME SUBSTRATE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; BREAST TUMOR; CELL CULTURE; FLUORESCENCE MICROSCOPY; GENETICS; KIDNEY; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CASPASES; CELLS, CULTURED; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DENDRITIC CELLS; DNA-BINDING PROTEINS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; IMMUNOPRECIPITATION; JURKAT CELLS; KIDNEY; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TRANSFECTION;

EID: 39049181784     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783991836     Document Type: Article

References (42)

1. Alderson, M. R.; Tough, T. W.; Davis-Smith, T.; Braddy, S.; Falk, B.; Schooley, K. A.; Goodwin, R. G.; Smith, C. A.; Ramsdell, F.; Lynch, D. H. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77; 1995.
2. Aravind, L.; Dixit, V. M.; Koonin, E. V. Apoptotic molecular machinery: Vastly increased complexity in vertebrates revealed by genome comparisons. Science 291:1279-1284; 2001.
3. Ashany, D.; Savir, A.; Bhardwaj, N.; Elkon, K. B. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 163:5303-5311; 1999.
4. Ashkenazi, A.; Dixit, V. M. Death receptors: Signaling and modulation. Science 281:1305-1308; 1998.
5. Barnhart, B. C.; Lee, J. C.; Alappat, E. C.; Peter, M. E. The death effector domain protein family. Oncogene 22:8634-8644; 2003.
6. Bjorck, P.; Banchereau, J.; Flores-Romo, L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int. Immunol. 9:365-372; 1997.
7. Brunner, T.; Mogil, R. J.; LaFace, D.; Yoo, N. J.; Mahboubi, A.; Echeverri, F.; Martin, S. J.; Force, W. R.; Lynch, D. H.; Ware, C. F. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444; 1995.
8. Chao, D. T.; Korsmeyer, S. J. Bcl-2 family: Regulators of cell death. Annu. Rev. Immunol. 16:395-419; 1998.
9. Chinnaiyan, A. M.; O'Rourke, K.; Yu, G. L.; Lyons, R. H.; Garg, M.; Duan, D. R.; Xing, L.; Gentz, R.; Ni, J.; Dixit, V. M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990-992; 1996.
10. Cohn, M. The immune system: A weapon of mass destruction invented by evolution to even the odds during the war of DNAs. Immunol. Rev. 185:24-38; 2002.
11. Dhein, J.; Walczak, H.; Baumler, C.; Debatin, K. M.; Krammer, P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438-441; 1995.
12. Earnshaw, W. C.; Martins, L. M.; Kaufmann, S. H. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:383-424; 1999.
13. Fernandes-Alnemri, T.; Armstrong, R. C.; Krebs, J.; Srinivasula, S. M.; Wang, L.; Bullrich, F.; Fritz, L. C.; Trapani, J. A.; Tomaselli, K. J.; Litwack, G.; Alnemri, E. S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93:7464-7469; 1996.
14. Fisher, G. H.; Rosenberg, F. J.; Straus, S. E.; Dale, J. K.; Middleton, L. A.; Lin, A. Y.; Strober, W.; Lenardo, M. J.; Puck, J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946; 1995.
15. Hengartner, M. O. The biochemistry of apoptosis. Nature 407:770; 2000.
16. Irmler, M.; Thome, M.; Hahne, M.; Schneider, P.; Hofmann, K.; Steiner, V.; Bodmer, J. L.; Schroter, M.; Burns, K.; Mattmann, C.; Rimoldi, D.; French, L. E.; Tschopp, J. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195; 1997.
17. Ju, S. T.; Panka, D. J.; Cui, H.; Ettinger, R.; el-Khatib, M.; Sherr, D. H.; Stanger, B. Z.; Marshak-Rothstein, A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448; 1995.
18. Kirchhoff, S.; Muller, W. W.; Krueger, A.; Schmitz, I.; Krammer, P. H. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165:6293-6300; 2000.
19. Kitsberg, D.; Formstecher, E.; Fauquet, M.; Kubes, M.; Cordier, J.; Canton, B.; Pan, G.; Rolli, M.; Glowinski, J.; Chneiweiss, H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 19:8244-8251; 1999.
20. Kramer, P. H. CD95's deadly mission in the immune system. Nature 407:789-795; 2000.
21. Lee, J. C.; Schickling, O.; Stegh, A. H.; Oshima, R. G.; Dinsdale, D.; Cohen, G. M.; Peter, M. E. DEDD regulates degradation of intermediate filaments during apoptosis. J. Cell. Biol. 158:1051-1066; 2002.
22. Lizard, G.; Fournel, S.; Genestier, L.; Dgedin, N.; Chaput, C.; Racher, M.; Mutin, M.; Panaye, G.; Revillard, J. P. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 21:275-283; 1995.
23. Matsue, H.; Edelbaum, D.; Hartmann, A. C.; Morita, A.; Bergstresser, P. R.; Yagita, H.; Okumura, K.; Takashima, A. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J. Immunol. 162:5287-5298; 1999.
24. Nagata, S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model. J. Hum. Genet. 43:2-8; 1998.
25. Nieda, M.; Kikuchi, A.; Nicol, A.; Koezuka, Y.; Ando, Y.; Ishihara, S.; Lapteva, N.; Yabe, T.; Tokunaga, K.; Tadokoro, K.; Juji, T. Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Valpha 24 natural killer T cells expressing CD40L. Immunology 102:137-145; 2001.
26. Phillips, R. E. Immunology taught by Darwin. Nat. Immunol. 3:987-989; 2002.
27. Rich, T.; Allen, R. L.; Wyllie, A. H. Defying death after DNA damage. Nature 407:777; 2000.
28. Rieux-Laucat, F.; Le Deist, F.; Hivroz, C.; Roberts, I. A.; Debatin, K. M.; Fischer, A.; de Villartay, J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349; 1995.
29. Roth, W.; Stenner-Liewen, F.; Pawlowski, K.; Godzik, A.; Reed, J. C. Identification and characterization of DEDD2, a death effector domain-containing protein. J. Biol. Chem. 277:7501-7508; 2002.
30. Scaffidi, C.; Schmitz, I.; Krammer, P. H.; Peter, M. E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541-1548; 1999.
31. Schickling, O.; Stegh, A. H.; Byrd, J.; Peter, M. E. Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ. 8:1157-1168; 2001.
32. Schulze-Osthoff, K.; Ferrari, D.; Los, M.; Wesselborg, S.; Peter, M. E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254:439-459; 1998.
33. Siegel, R. M.; Frederiksen, J. K.; Zacharias, D. A.; Chan, F. K.; Johnson, M.; Lynch, D.; Tsien, R. Y.; Lenardo, M. J. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288:2354-2357; 2000.
34. Singer, G. G.; Abbas, A. K. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371; 1994.
35. Stegh, A. H.; Schickling, O.; Ehret, A.; Scaffidi, C.; Peterhansel, C.; Hofmann, T. G.; Grummt, I.; Krammer, P. H.; Peter, M. E. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. 17:5974-5986; 1998.
36. van Engeland, M.; Nieland, L. J.; Ramaekers, F. C.; Schutte, B.; Reutelingsperger, C. P. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9; 1998.
37. van Parijs, L.; Ibraghimov, A.; Abbas, A. K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321-328; 1996.
38. Varfolomeev, E. E.; Boldin, M. P.; Goncharov, T. M.; Wallach, D. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: Proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183:1271-1275; 1996.
39. Vincenz, C. A.; Dixit, V. M. Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-meiated death signaling. J. Biol. Chem. 272:6578-6583; 1997.
40. Wesch, D.; Marx, S.; Kabelitz, D. Monocyte-dependent death of freshly isolated T lymphocytes: Induction by phorbolester and mitogens and differential effects of catalase. J. Immunol. 161:1248-1256; 1998.
41. Yokota, A.; Oikawa, A.; Matsuda, C.; Shinohara, N.; Eshima, K. Cell-mediated Fas-based lysis of dendritic cells which are apparently resistant to anti-Fas antibody. Microbial. Immunol. 47:285-293; 2003.
42. Zhao, Z.; Huang, X.; Li, N.; Chen, S.; Cao, X. Direct cloning of cell differential expression genes with full-length by a new strategy based on the multiple rounds of "long distance" PCR and magnetic beads mediated subtraction. J. Biotech. 73:35-41; 1999.